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Exposure to alkyl anilines may lead to bladder cancer, which is the second most frequent cancer of the urogenital tract. 
3,5-dimethylaniline is highly used in industry. Studies on its primary metabolite 3,5-dimethylaminophenol (3,5-DMAP) 
showed that this compound causes oxidative stress, changes antioxidant enzyme activities, and leads to death of different 
mammalian cells. However, there is no in vitro study to show the direct effects of 3,5-DMAP on human bladder and 
urothelial cells. Selenocompounds are suggested to decrease oxidative stress caused by some chemicals, and selenium 
supplementation was shown to reduce the risk of bladder cancer. The main aim of this study was to investigate whether 
selenocompounds organic selenomethionine (SM, 10 µmol/L) or inorganic sodium selenite (SS, 30 nmol/L) could reduce 
oxidative stress, DNA damage, and apoptosis in UROtsa cells exposed to 3,5-DMAP. 3,5-DMAP caused a dose-dependent 
increase in intracellular generation of reactive oxygen species, and its dose of 50 µmol/L caused lipid peroxidation, protein 
oxidation, and changes in antioxidant enzyme activities in different cellular fractions. The comet assay also showed 
single-strand DNA breaks induced by the 3,5-DMAP dose of 50 µmol/L, but no changes in double-strand DNA breaks. 
Apoptosis was also triggered. Both selenocompounds provided partial protection against the cellular toxicity of 3,5-DMAP. 
Low selenium status along with exposure to alkyl anilines can be a major factor in the development of bladder cancer. 
More mechanistic studies are needed to specify the role of selenium in bladder cancer.
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Bladder cancer is the sixth most common cancer in men 
and the 17th in women. Almost 550,000 new cases were 
reported in the world in 2018 alone (1–3). It accounts for 
about 7% of all cancer incidence in men. In the European 
Union countries, it is the fourth most common cancer among 
men (4). Annual incidence is 36/100,000 in men and 
10/100,000 in women, and mortality 13/100,000 in men, 
and 4/100,000 in women. Its incidence and prevalence rise 
after the age of 60 (5).
Well-established risk factors are tobacco consumption, 
occupational exposure (particularly to monocyclic aromatic 
amines and polycyclic aromatic hydrocarbons), and 
infection with Schistosoma hematobium (6, 7). Other risk 
factors include alcohol consumption, high coffee 
consumption, low fruit and vegetable consumption, low 
vitamin and trace element intake (low selenium and vitamin 
E intake in particular), exposure to drinking water 
contaminated with environmental chemicals, and some 
medical treatments (7–9).
Exposure to environmental alkyl amines/alkyl anilines, 
aniline dyes, and other aromatic amines, which originate 
from multiple sources, is also a well-documented risk factor 
for this disease. For example, tobacco smoke, which 
contains high levels of aromatic amines, increases the risk 
of bladder cancer from two to five times (1). These 
chemicals are also present in hair dyes, combustion 
products, pharmaceuticals, and pesticides (8).
Workers exposed to o-toluidine, aniline, and 
nitrobenzene at a rubber chemical manufacturing plant in 
New York had nearly three times higher bladder cancer 
incidence than the New York State general population. 
Smoking habits were suggested to account for only 8% 
higher bladder cancer incidence in that cohort (7). A non-
occupational epidemiological study in the Los Angeles 
County showed that 2,6-dimethylaniline (2,6-DMA), 
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3,5-dimethylaniline (3,5-DMA), and 3-ethylaniline (3-EA), 
were significantly associated with bladder cancer incidence, 
regardless of smoking (10).
3,5-dimethylaniline is used in the production of azo 
dyes, pharmaceuticals, antioxidants, detergents, wood 
preservatives, textiles, metal complexes, and antiozonants 
(8). Like other aromatic amines, 3,5-DMA is metabolised 
by cytochrome P450 enzymes (CYP450) through 
N-hydroxylation. N-hydroxy-3,5-dimethylaniline (N-OH-
3,5-DMA) is a direct mutagen, supporting the evidence that 
N-hydroxylation of such compounds is a bio-activation 
step. The parent compound, 3,5-DMA, has also been shown 
to bind to DNA in laboratory animals, but there is no 
sufficient evidence of DNA adduct formation in humans 
(11). 3,5-dimethylaminophenol (3,5-DMAP), in turn, is 
either a product of 3,5-DMA oxidation or a N-OH-3,5-DMA 
hydroxylation metabolite catalysed by CYP450. 3,5-DMAP 
can be metabolised into 3,5-dimethylquinone imine (3,5-
DMQI), which undergoes further redox cycling, whose 
by-products are reactive oxygen species (ROS), H2O2 and 
hydroxyl (•OH) radicals in particular (12).
In our earlier studies (11–14), 3,5-DMAP induced ROS 
production, cytotoxicity, and genotoxicity in Chinese 
hamster ovary (CHO) cells. It also up-regulated caspase 3 
and 8 activities and activated apoptosis.
If not counteracted by antioxidants and intracellular 
antioxidant systems, ROS damages important cellular 
molecules, including proteins, lipids, and DNA (15). Low 
antioxidant levels, low selenium in particular, increase the 
risk of several types of malignancies, including bladder 
cancer (16, 17). Selenium is a component of several 
antioxidant enzymes, namely glutathione peroxidases (GPx) 
and thioredoxin reductases (TrxR) (18, 19). We have 
previously shown that organic and inorganic selenium 
protect against oxidative stress produced by a wide variety 
of chemicals (20, 21).
Recently, we found that N-acetylcysteine (NAC), 
ascorbic acid (Asc), and selenocompounds protect modified 
CHO cells, including gpt-transgenic As52, aprt-transgenic 
AA8, and aprt-transgenic/NER-deficient UV5 cells, from 
oxidative damage caused by 3,5-DMAP (12–14). However, 
no effects of alkyl amine/alkyl aniline metabolites on the 
UROtsa cells have been examined so far. Considering that 
the urothelium is one of the targets of aromatic amine-
induced carcinogenesis, we conducted this study to evaluate 
the protective effects of inorganic selenium (sodium 
selenite, SS) and organic selenium (selenomethionine, SM) 
against the cytotoxic, oxidant, and genotoxic properties of 
3,5-DMAP in UROtsa cells. Additionally, we assessed the 
protective effects of ascorbic acid (Asc) and N-acetylcysteine 




All chemicals, including SS, SM, and the protease 
inhibitor cocktail, were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). All cell culture reagents were purchased 
from Lonza (Walkersville, MD, USA) or Sigma-Aldrich. 
Molten normal melting point agarose, low melting point 
agarose, and fluorescence dyes SYBR Gold and Hoechst 
33258 were purchased from Molecular Probes/Invitrogen 
(Eugene, OR, USA). GelBond film was obtained from 
Lonza. Bottomless 96-well plates for the comet assay were 
purchased from Greiner BioOne (Monroe, NC, USA).
Kits
Nuclear and cytoplasmic extraction kits were purchased 
from Thermo Fisher Scientific (Rockford, IL, USA). Cell 
proliferation reagent (2-(4-iodophenyl)- 3-(4-nitrophenyl)-
5-(2,4-disulfophenyl)-2H tetrazolium, monosodium salt) 
(WST-1) kit was purchased from Roche Applied Science 
(Indianapolis, IN, USA). 5-(and 6-) chloromethyl-2’,7’-
dichlorodihydrofluorescein diacetate (CM-H2DCFA) ROS 
detection kit was from Molecular Probes/Invitrogen. All 
other assay kits were from Sigma-Aldrich, except the 
thiobarbituric acid reactive substance (TBARS) and 
carbonyl assay kits (Cayman Chemical Company, Ann 
Arbor, MI, USA).
Synthesis of 3,5-dimethyaminophenol
3,5-DMAP was synthesised in our lab as described by 
Chao et al. (12). Briefly, a mixture of sulphanilic acid, 
sodium carbonate, and water was heated to 60 °C and then 
cooled in an ice bath. Sodium nitrite solution was added, 
and the resulting solution was poured on HCl solution 
(aqueous, 5.6% w/v) in an ice bath and kept for 15 min. 
This solution was added to 2,6-dimethylphenol solution (in 
aqueous NaOH and water) at 5 °C. The dark red reaction 
mixture was stirred well and kept at 25 °C for 1 h. Later, it 
was heated to 60 °C, and aqueous sodium hydrosulphite 
(1% w/v) was gradually added till yellow crystals were 
precipitated. After waiting for 15 min at 50 °C, the yellow 
suspension was cooled to 20 °C and then filtered. The filtrate 
was then washed with sodium hydrosulphite (1% w/v in 
water) and dried under vacuum. The final yield of 3,5-
DMAP was 82%.
Cell culture and treatment
Cells of the UROtsa line were obtained from Thermo 
Fischer Scientific. UROtsa line is a primary culture of 
normal human urothelium isolated through immortalisation 
with a construct containing the SV40 large T antigen. In 
Dulbecco’s Modified Eagle’s Medium (DMEM) cells were 
grown as a monolayer in plastic flasks, containing foetal 
bovine serum (FBS, 5%, v/v) and glucose (1 mg/mL). The 
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cells were fed on fresh medium every three days and grown 
until reaching about 90% confluence. Confluent cultures 
were subcultured at a 1:4 ratio in a humidified atmosphere 
with 5% CO2 at 37 ºC. Prior to all experiments, UROtsa 
cells were cultured with a 1:1 mixed serum-free medium 
of DMEM and Ham’s F-12, supplemented with insulin 
(5 μg/mL), hydrocortisone (36 ng/mL), and EGF (10 ng/
mL) for two days. For the experiments UROtsa cells (106) 
were plated in plastic flasks. After exposure, they were 
trypsinised and held at -80 °C until preparation of 
cytoplasmic and nuclear fractions. Cells exposed to 3,5-
DMAP for 1 h were washed twice with fresh serum-free 
medium and then incubated in a fresh medium at 37 °C for 
another 24 h.
The experimental design is described in Table 1. Our 
preliminary 3,5-DMAP cytotoxicity experiments on the 
UROtsa cells included a wide dose range (1–1000 µmol/L) 
for several reasons. One was to determine the half-maximal 
inhibitory concentration (IC50) for cell viability, and the 
other was to follow producers’ kit protocol recommendations 
for one-hour exposure in the ROS experiments. The IC50 
was determined to be 100 µmol/L, IC70 50 µmol/L, and IC80 
25 µmol/L. As the IC80 (25 µmol/L) did not cause significant 
effects on oxidative stress parameters on the UROtsa cells, 
we selected the IC70 dose (50 µmol/L) for all subsequent 
experiments.
The Asc and NAC (±DMAP) treated groups were used 
for cytotoxicity and ROS assessments, while the SS and 
SM (±DMAP) groups were used for cytotoxicity, ROS, 
antioxidant parameter, apoptosis, and genotoxicity 
measurements.
The concentrations of SS and SM were chosen from 
preliminary experiments considering maximum glutathione 
peroxidase 1 (GPx1) induction (20–25). They were in the 
same ranges that were applied previously for several other 
cell types. The concentration of Asc and NAC was chosen 
based on our previous studies (10–12).
Exposure times of 24 and 72 h were also based on our 
previous studies with 3,5-DMAP (13, 14). Because the 
results obtained from the 24- and 72-hour treatment groups 
of both SS and SM were similar in most parameters 
measured, only the 24-hour results are included in the 
Results section.
Nuclear and cytoplasmic extract preparation
After centrifugation at 500 × g for 5 min, cell pellets 
were washed with PBS and re-centrifuged at 500 × g for 
3 min. The supernatant was discarded and the obtained dry 
pellet used to obtain nuclear and cytoplasmic cellular 
fractions using a nuclear and cytoplasmic extraction kit (in 
the presence of a protease inhibitor cocktail).
Determination of cytotoxicity
The cytotoxicity assay was performed with a WST-1 
kit. After treatment, the cells were washed with PBS, 
suspended in 1 mL of fresh medium, and then pipetted into 
96-well plates. WST-1 was added to each well, and the cells 
incubated in the dark at 37 °C for 1 h.
Formazan absorbance was quantified with a 
spectrophotometer (SpectraMax® Microplate Reader, 
Molecular Devices, San Francisco, CA, USA) at 495 nm 
and SoftMax Pro software (Molecular Devices, Sunnyvale, 
CA). ROS production in the cells was adjusted to negative 
control (assuming their ROS production as 100%).
Quantification of intracellular ROS
Intracellular ROS was detected with a CM-H2DCFA 
ROS detection kit, which dyes living cells in fluorescent 
green.
The cells of either group were washed with PBS and 
suspended in 1 mL wells with serum-free medium. Cell 
suspension solutions were pipetted into 96-well plates and 
mixed with DMEM containing CM-H2DCFDA (final 
concentration in each well: 25 µmol/L), activated by pre-
incubation at 37 °C for 30 min. Generated ROS was detected 
immediately on a SpectraMax® Microplate Reader (λexcitation: 
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Table 1 Experimental design
Experimental groups of UROtsa cells Pretreatment Treatment
Control # - -
SS SS (30 nmol/L) for 24 h
SM SM (10 µmol/L) for 24 h
DMAP 3,5-DMAP (50 µmol/L) for 1 h*
SS/DMAP SS (30 nmol/L) for 24 h 3,5-DMAP (50 µmol/L) for 1 h* 
SM/DMAP 10 µmol/L SM for 24 h 3,5-DMAP (50 µmol/L) for 1 h* 
Asc Asc (50 mg/mL) for 24 h
Asc/DMAP Asc (50 mg/mL) for 24 h 3,5-DMAP (50 µmol/L) for 1 h* 
NAC NAC (5 mmol/L) for 24 h
NAC/DMAP NAC (5 mM) for 24 h 3,5-DMAP (50 µmol/L) for 1 h* 
Control – UROtsa cells with 90% confluence; SS – sodium selenite; SM – selenomethionine; DMAP – 3,5 dimethyaminophenol;  Asc 
– ascorbic acid; NAC – N-acetylcysteine; * serum-free medium; The choice of the IC70 dose of 3,5-DMAP (50 µmol/L) was based on 
preliminary cytotoxicity experiments conducted on a wide dose range (1–1000 µmol/L)
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485 nm, λemission: 530 nm) and quantified with SoftMax Pro 
software. ROS production was adjusted to negative control.
Determination of antioxidant enzyme activities
The activity of GPx1, a selenoenzyme mediating lipid 
peroxide and H2O2 reduction was measured with a 
respective Sigma Aldrich kit (see above) (18). TrxR activity 
was determined with an activity assay kit which can 
measure the reduction of the substrate 5,5’-dithiobis(2-
nitrobenzoic) acid (DTNB) to 5-thio-2-nitrobenzoic acid 
(TNB) at 412 nm (19). Catalase (CAT) activity was 
determined with a colorimetric assay kit by measuring the 
enzymatic decomposition of H2O2 at 520 nm. Total 
superoxide dismutase (SOD) activity was measured with a 
total SOD activity kit. The inhibition of SOD activity was 
determined colorimetrically by measuring the reduction in 
the color development at 440 nm.
Glutathione reductase (GR) activity was determined 
with a GR activity assay kit. This assay mainly depends on 
the reduction of GSSG in the presence of NADPH, DTNB, 
and GR. Glutathione-S-transferase activity was determined 
with an assay kit using 1-chloro-2,4 dinitrobenzene (CDNB) 
as a substrate at 340 nm according to Habig et al. (26).
Determination of total, reduced, and oxidised glutathione 
levels
Total glutathione (GSH) concentrations of different 
cellular compartments were determined with a total 
glutathione assay kit. For the quantification of GSSG, 
reduced GSH was blocked by the addition of 2-vinylpyridine 
in the presence of triethanolamine. GSH concentrations 
were calculated using the following equation: GSH = (total 
GSH-2xGSSG). Cytoplasmic and nuclear redox ratio 
([GSH]/[GSSG]) was calculated by dividing the GSH 
concentration with the GSSG concentration.
Determination of lipid peroxidation
Lipid peroxidation in nuclear and cytoplasmic extracts 
was quantified by measuring the concentration of 
thiobarbituric acid reactive substance (TBARS) 
spectrofluorometrically using a TBARS assay kit (27), as 
it reflects malondialdehyde (MDA) concentrations, and the 
results were expressed as µmol/g of protein.
Determination of protein oxidation
The most commonly used indicator of protein oxidation 
is protein carbonyl content (28), which was measured with 
a carbonyl assay kit at 360 nm spectrophotometrically.
Total protein determination
Protein content of the samples was determined with the 
bicinchoninic acid (BCA) protein assay kit. The absorbance 
values of the samples were measured at 562 nm, and the 
results expressed as mg/mL (29).
Determination of caspase 3 and caspase 8 activities
Caspase 3 activity was measured with a colorimetric 
assay kit based on hydrolysis of the peptide substrate acetyl-
Asp-Glu-Val-Asp p-nitroanilide (AcDEVD-pNA), which 
results in release of the p-nitroaniline (pNA) moiety. Total 
pNA released from the substrate was calculated from the 
absorbance values at 405 nm or from a calibration curve 
obtained from pNA standards.
Caspase 8 activity was also measured with a colorimetric 
assay kit based on the hydrolysis of the peptide substrate 
Acetyl-Ile-Glu-Thr-Asp p-nitroaniline (Ac-IETDpNA), 
which results in the release of a pNA moiety. Total pNA 
released from the substrate was determined from the 
absorbance values at 405 nm or from a standard pNA 
calibration curve.
Comet assay
Comet assay is a sensitive, fast, and flexible method 
that can easily detect DNA damage caused by environmental 
chemicals on different cell types. It is also useful in 
evaluating the ability of antioxidants/micronutrients to 
protect the integrity of the genetic material (30). The 
CometChip protocol, first described by Wood et al. (31), is 
gaining significant importance for high throughput DNA 
damage analysis.
Single strand breaks (SSBs) were determined using the 
alkaline CometChip protocol, while double strand breaks 
(DSBs) were detected using the neutral CometChip 
protocol. Briefly, for SSB determination, treated UROtsa 
cells (100 µL, 106 cells/mL) were pipetted into a bottomless 
96-well plate and captured by gravity. The plate was then 
removed and the gel covered with 1% low melting point 
agarose. The cells were loaded to CometChips and lysed 
in a lysis buffer. This buffer consisted of 0.3 mol/L NaOH, 
2.5 mol/L NaCl, 10 mmol/L Tris, 1% Triton X, and 
1 mmol/L Na2EDTA. After overnight lysis, they were 
electrophoresed in a cold alkaline electrophoresis buffer 
(0.3 mol/L NaOH and 1 m mol/L Na2EDTA) at 4 °C for 
40 min. The chips were then neutralised twice in fresh buffer 
(0.4 mol/L Tris-HCl at pH 7.5) at 4 °C for 15 min and stained 
with SYBR Gold according to the manufacturer’s 
instructions for fluorescence imaging. Images were captured 
using a Nikon 80i upright microscope (Nikon Instruments, 
Tokyo, Japan) coupled with an automatic scanning system 
and analysed with a customised Guicometanalyzer software 
by MATLAB (The Mathworks, Natick, MA, USA).
For DSB determination, the gels were lysed in a neutral 
lysis buffer [2.5 mol/L NaCl, 2 mmol/L Na2EDTA, 
10 mmol/L Tris, 1% N-lauroylsarcosine, pH 9.5 with 0.5% 
Triton X-100, and 10% dimethyl sulphoxide (DMSO) added 
20 min before use] at 43 °C for 4 h. Chips were then washed 
three times with the electrophoresis buffer (90 mmol/L Tris, 
90 mmol/L boric acid, and 2 mmol/L Na2EDTA, pH 8.5) 
for 30 min and electrophoresed at 4 °C for 1 h. After 
neutralisation, the CometChips were stained with SYBR 
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Gold for fluorescence imaging. Images were captured and 
analysed in the same manner as with the alkaline CometChip 
protocol. For DNA damage parameters we took %tail DNA 
as the level of DNA damage and olive tail moment (OTM, 
which represents the product of comet length and tail 
intensity).
Untreated cells were used as controls, cells treated with 
H2O2 (100 µmol/L) as positive control, and cells treated 
with 1% DMSO as solvent control. All experiments were 
done in at least triplicate for each group.
Statistical analysis
The results obtained from triplicate measurements were 
expressed as mean ± standard deviation (SD) and analysed 
with the Statistical Package for Social Sciences Program 
(SPSS) version 17.0 (Chicago, IL, USA) to compare the 
study groups. Differences between the groups were 
evaluated with the Kruskal-Wallis one-way analysis of 
variance (ANOVA) and later with the Mann Whitney U-test. 
P values below 0.05 were considered statistically significant.
RESULTS AND DISCUSSION
Cytotoxicity and ROS production caused by 3,5-DMAP 
and protection by antioxidants
Treatment of UROtsa cells with SS, SM, Asc, or NAC 
alone caused no detectable cytotoxicity, whereas 3,5-DMAP 
caused a dose-dependent increase in cytotoxicity.
All antioxidants protected the cells against cytotoxicity 
caused by 3,5-DMAP (Figure 1). 3,5-DMAP significantly 
increased intracellular ROS generation, and all antioxidants 
lowered it significantly. Asc and NAC provided almost full 
protection, and SS and SM only partial protection (Figure 
2). At the IC50 of 3,5-DMAP, SS pretreatment restored cell 
viability to 100%, and SM increased it to 95%. All the 
oxidant and antioxidant parameters were also detected in 
the nucleus but were two to nine times lower than in the 
cytoplasm.
Similar protective properties of SS and SM against the 
cytotoxic and ROS-producing effects of 3,5-DMAP were 
also found in AS52 CHO cells. However, the IC50 of 3,5-
DMAP in AS52 CHO cells was one quarter of ours, 
25 µmol/L (13, 14). Considering our previous findings, we 
believe that UROtsa cells are more resistant to the cytotoxic 
effects of 3,5-DMAP, perhaps because the UROtsa cells 
are derived from primary cells and then immortalised. 
However, even though human urothelial cells have a higher 
IC50 than different strains of CHO cells, in real life urothelial 
cells are exposed to many other chemicals and their 
metabolites besides alkyl aniline metabolites, and their 
combined effects may lead to carcinogenic changes. These 
combined effects should be investigated in future studies.
Selenoenzymes
Selenoenzymes, GPxs in particular, protect cells from 
oxidative damage caused by peroxides (18). TrxRs are 
responsible for the reduction of thioredoxin, which is a very 
Figure 1 Cell viability expressed in the percentage of control. Values are given as means ± SD of duplicate measurements of three 
flasks per group; 3,5-DMAP – 3,5-dimethylaminophenol; SM – selenomethionine; SS – sodium selenite; A – cell viability after exposure 
to 3,5-DMAP for 1 h (DMAP) or in the group pretreated with SS for 24 h and then treated with 3,5-DMAP for 1 h (SS/DMAP); B – 
cell viability after exposure to 3,5-DMAP for 1 h (DMAP) or in the group pretreated with SM for 24 h and then with 3,5-DMAP for 
1 h (SM/DMAP); C – cell viability after exposure to 3,5-DMAP for 1 h (DMAP) or in the group pretreated with ascorbic acid (Asc) 
for 24 h and then with 3,5-DMAP for 1 h (Asc/DMAP); D: cell viability after exposure to 3,5-DMAP for 1 h (DMAP) or in the group 
pretreated with N-acetylcysteine (NAC) for 24 h and then with 3,5-DMAP for 1 h (NAC/DMAP); *, #, &, and • – significantly higher than 
DMAP (p<0.05)
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important protein in many biological processes, including 
redox signalling (19). Cytoplasmic and nuclear 
selenoenzyme activities are summarised in Table 2. As 
expected, both SS and SM treatments significantly increased 
GPx1 and TrxR activities in both the cytoplasm and nucleus. 
3,5-DMAP treatment, in turn, lowered them significantly. 
Combined SS and SM treatment with 3,5-DMAP resulted 
in significant restoration of cytoplasmic and nuclear GPx1 
and TrxR activities to nearly control levels.
These and similar drops in GPx1 and TrxR activities in 
our previous studies may be related to lower expression of 
these antioxidant proteins but also to post-translational 
modification caused by 3,5-DMAP exposure. Further 
mechanistic studies are needed to investigate post-
transcriptional or post-translational effects of alkyl anilines 
and their metabolites on selenoproteins. Moreover, 
selenoprotein P expression/level should also be measured 
in vivo after applying 3,5-dimethylaniline, as it is the most 
important antioxidant selenoprotein in eukaryotic plasma, 
epithelial, and endothelial cells.
Antioxidant enzymes
One-hour exposure to 50 µmol/L of 3,5-DMAP 
exposure led to substantial changes in cellular antioxidant/
oxidant parameters in UROtsa cells, indicating a shift in 
the redox equilibrium towards oxidation. Table 3 shows the 
activities of cytoplasmic and nuclear antioxidant enzymes. 
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Control 0.221±0.012 0.468±0.012 0.056±0.001 0.0660.003
SS 0.347±0.015* 0.691±0.056* 0.071±0.004* 0.098±0.005*
SM 0.326±0.029* 0.698±0.061* 0.067±0.002* 0.091±0.011*
DMAP 0.127±0.018*,#,& 0.316±0.042*,#,& 0.034±0.001*,#,& 0.041±0.010*,#,&
SS/DMAP 0.199±0.016 0.567±0.048 0.052±0.002 0.065±0.005
SM/DMAP 0.213±0.019 0.521±0.064 0.058±0.003 0.059±0.012
DMAP – 3,5-dimethylaminophenol (one-hour treatment with the IC70 dose of 50 µmol/L); GPx1: glutathione peroxidase 1; SS – 24-
hour pretreatment with sodium selenite; SM – 24-hour pretreatment with selenomethionine; TrxR – thioredoxin reductase; Values are 
given as means ± SD of duplicate measurements of three flasks per group; * significantly different from control (p<0.05); # significantly 
different from the SS/DMAP group (p<0.05); & significantly different from the SM/DMAP group (p<0.05)
Figure 2 Intracellular ROS production expressed in the percentage of control. Values are given as means ± SD of duplicate measurements 
of three flasks per group; 3,5-DMAP – 3,5-dimethylaminophenol ; SM – selenomethionine; SS – sodium selenite; A – ROS production 
after exposure to 3,5-DMAP for 1 h (DMAP) or in the group pretreated with SS for 24 h and then treated with 3,5-DMAP for 1 h (SS/
DMAP); B: ROS production after exposure to 3,5-DMAP for 1 h (DMAP) or in the group pretreated with SM for 24 h and then with 
3,5-DMAP for 1 h (SM/DMAP); C: ROS production after exposure to 3,5-DMAP for 1 h (DMAP) or in the group pretreated with 
ascorbic acid (Asc) for 24 h and then with 3,5-DMAP for 1 h (Asc/DMAP); D: ROS production after exposure to 3,5-DMAP for 1 h 
(DMAP) or in the group pretreated with N-acetylcysteine (NAC) for 24 h and then with 3,5-DMAP for 1 h (NAC/DMAP); *, #, &, and 
• – significantly lower than DMAP (p<0.05)
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3,5-DMAP significantly lowered both cytoplasmic and 
nuclear GPx1 and TrxR activities, which was counteracted 
by SS and SM treatment (Table 3). The same phenomenon 
was also observed in AA8 and AS52 CHO cells (13, 14).
SS and SM treatment significantly increased the 
cytoplasmic, but not nuclear CAT and SOD activities. 
DMAP exposure significantly decreased cytoplasmic CAT 
(35%), GR (45%), and GST (28%) activities and caused a 
significant (twofold) increase in cytoplasmic SOD activity. 
3,5-DMAP treatment also significantly decreased nuclear 
CAT (36%), GR (22%), and GST (48%) activities. Nuclear 
SOD activity dropped 1.5 times (p<0.05).
Almost the same results were previously found in AA8 
and AS52 CHO cells (12-14), which clearly points to 3,5-
DMAP causing an imbalance between cellular enzymatic 
antioxidants and cellular oxidants in different eukaryotic 
cells. This needs to be confirmed by future in vivo 
experiments, which should also establish the expression of 
enzymatic antioxidants.
Total, oxidised, and reduced glutathione levels
Cellular thiols, GSH in particular, play an important 
role in maintaining cellular redox status (32). The effects 
of 3,5-DMAP (50 µmol/L) on total, oxidised, and reduced 
GSH levels and intracellular redox ratios are summarised 
in Table 4. DMAP significantly lowered total GSH levels 
in the cytoplasm compared to control. In the SS/DMAP and 
SM/DMAP treatment groups (data not shown for 72 h 
groups because there were no differences between 24-hour 
and 72-hour treatment) total GSH levels were significantly 
higher than in the DMAP alone group. 3,5-DMAP increased 
cytoplasmic GSSG levels 2.3 times (p<0.05). In cells 
pretreated with SS and SM  they dropped significantly but 
not to control levels. The cytoplasmic redox ratio was 
significantly higher in the groups treated with SS and SM 
alone than in controls (p<0.05). 3,5-DMAP decreased the 
redox ratio 2.7 times. Nuclear total GSH levels increased 
significantly in the SS and SM groups and decreased 
significantly (1.6 times) in the DMAP group. In the SS/
DMAP and SM/DMAP groups, total GSH levels were 
significantly higher than in the DMAP group.
Due to decreases in total GSH levels in the DMAP alone 
group, nuclear GSSG levels were lower than control 
(p<0.05). Nuclear redox ratio was significantly higher in 
the SS and SM groups. 3,5-DMAP lowered the ratio 2.7 
times vs. control while pretreatment with SS and SM 
restored the ratio to control levels.
Lipid peroxidation and protein oxidation
Data regarding lipid peroxidation (TBARS) and protein 
oxidation are also given in Table 4. Cytoplasmic lipid 
peroxidation levels were 6.6 times higher in the DMAP 
group (50 µmol/L) vs. control (p<0.05). Pretreatment with 
SS and SM decreased lipid peroxidation significantly, but 





































































































































































































































































































































































































































































































































































































































































25Erkekoglu P, et al. Antioxidants and selenocompounds inhibit 3,5-dimethylaminophenol toxicity to human urothelial cells Arh Hig Rada Toksikol 2019;70:18-29
SM/DMAP groups were still significantly higher than in 
control (4.7 and 4.8 times, respectively). Nuclear lipid 
peroxidation was 1.5 times higher in the DMAP group than 
control (p<0.05). In the SS/DMAP and SM/DMAP it was 
restored to control levels.
Increased lipid peroxidation is known to facilitate 
protein oxidation. The best biomarker of protein oxidation 
is protein carbonylation (33). However, protein oxidation 
can arise independently (33, 34), and protein peroxides can 
induce lipid oxidation via radical-mediated reactions 
(33–35). We found that cytoplasmic and nuclear protein 
oxidation increased significantly in 3,5-DMAP treated cells 
as evidenced by increases in protein carbonyl levels (Table 
4). 3,5-DMAP treatment increased cytoplasmic carbonyl 
levels (indicator of protein oxidation) 1.9 times compared 
to control. Pretreatment with SS and SM reduced 
cytoplasmic protein oxidation, but it remained significantly 
higher than in control (1.5 times in the SS/DMAP group 
and 1.4 times higher in the SM/DMAP). Nuclear carbonyl 
levels were also 1.9 times higher in the DMAP group than 
control cells, and remained significantly higher in the SS/
DMAP and SM/DMAP groups (1.7 and 1.6 times, 
respectively).
Our results suggest that protein carbonyl levels 
increased due to increases in lipid peroxidation. Similar 
results were reported for CHO AS52 and AA8 cells (12-14). 
All these studies clearly show that increases in lipid 
peroxidation may significantly lead to protein oxidation 
(33–35), and oxidised proteins lose their ability to interact 
with cellular processes, which may also lower the activities 
of enzymatic antioxidants.
CometChip
Overproduction of ROS and increased lipid peroxidation 
combined with insufficient antioxidant enzymes causes 
different types of DNA damage (36). Even though the major 
DNA lesions are caused by direct oxidation of DNA bases, 
modifications caused by lipid peroxidation products, MDA 
in particular, may damage DNA nearly as much as direct 
base oxidation. MDA reacts with guanine, adenine, and 
cytosine to form cyclic pirymido-[1,2α] purine-10(3H)-
one-2′-deoxyribose (M1dG) adduct, the major MDA-DNA 
adduct in rodent and human tissues. M1dG induces 
transversions (particularly to T) and transitions (especially 
to A) with a frequency comparable with that of 8-oxoG in 
Escherichia coli (35, 36).
Figure 3 shows DNA damage induced by 3,5-DMAP 
(50 µmol/L). Neither SS nor SM alone reduced the olive 
tail moment (OTM), whereas 3,5-DMAP significantly 
increased both the %tail DNA (25%) and OTM (24%) 
compared to control. Pretreatment with SS and SM 
significantly lowered %tail DNA (24% and 26%, 
respectively) as well as OTM (17% and 20%, respectively). 
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Figure 3 %tail DNA and OTM values obtained with the alkaline CometChip assay; OTM – olive tail moment; DMAP – 
3,5-dimethylaminophenol (IC70 dose of 50 µmol/L); SM – selenomethionine; SS – sodium selenite; 
* significantly higher than in control; 
# significantly higher than in SS/DMAP; & significantly higher than in SM/DMAP
Figure 4 Caspase 3 and caspase 8 activities in the study groups. Values are given as means ± SD of duplicate measurements of three 
flasks per group; A – Caspase 3 activity in the groups pretreated with SS or SM for 24 h; B – Caspase 3 activity in the groups pretreated 
with SS or SM for 72 h; C – Caspase 8 activity in the groups pretreated with SS or SM for 24 h; D – Caspase 8 activity in the groups 
pretreated with SS or SM for 72 h); DMAP – 3,5-dimethylaminophenol (IC70 dose of 50 µmol/L); SM – selenomethionine; SS – sodium 
selenite; * significantly different from control; # significantly different from SS/DMAP; & significantly different from SM/DMAP
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DNA and OTM after 3,5-DMAP treatment, perhaps because 
of its lower sensitivity to the alkaline comet assay.
Significantly increased %tail DNA and OTM in the 
3,5-DMAP-treated cells confirm its damaging potential in 
the DNA. Our previous study (14) showed a similar 
decrease in DNA damage in CHO AS52 cells pretreated 
with SS and SM. Other studies also confirm their protective 
effect against DNA damage induced by a variety of 
compounds, including phthalates.
The results of CometChip clearly show that 3,5-DMAP 
causes DNA damage, possibly through the oxidation of 
DNA bases. Studies on a wider spectrum (with mechanistic 
data) than ours should be able to show what types of DNA 
damage 3,5-DMAP exposure can cause. As most of the 
DNA damage is related to the oxidation of guanine 
(8-oxodeoxyguanine formation), measurements of DNA 
repair protein levels [8-oxoguanine glycosylase (OGG1) in 
particular] should be able to show how 3,5-DMAP affects 
the base excision repair pathway.
Caspase 3 and 8 activities
Caspases are a family of protease enzymes playing 
essential roles in apoptosis. Caspase 8 is an initiator caspase 
that leads to the activation of caspase 3 as an executioner 
caspase. Figure 4 summarises cellular caspase 3 and caspase 
8 activities in our study. 3,5-DMAP caused a significant 
(87%) increase in caspase 3 activity, while pretreatment 
with SS and SM lowered it 46% and 45% (p<0.05), 
respectively in the first 24 h. After 72 h SS lowered it 58% 
and SM 57%.
Caspase 8 activity rose 39% in the DMAP group in 
respect to control, while pretreatment with SS lowered it 
33% and with SM 31% after 24 h compared to DMAP alone 
(p<0.05). After 72 h, SS pretreatment also resulted in a 
significant decrease in caspase 8 activity. Due to a high 
standard deviation in the SM pretreatment group, this drop 
was not significant.
Apoptosis is characterised by lower cellular GSH 
content (37), and our findings of reduced GSH levels and 
apoptosis induction in 3,5-DMAP-treated cells confirm that 
association. They also confirm the protective effects of the 
tested selenocompounds against cell death caused by this 
alkyl aniline metabolite. Similar results were previously 
reported for CHO AA8 and AS52 cells (12–14).
Our results clearly point to 3,5-DMAP as the cause of 
apoptosis in human urothelial cells. However, other forms 
of cell death, autophagy in particular (as well as different 
autophagic markers), should also be investigated in order 
to determine the mechanism of cell death caused by alkyl 
anilines.
In conclusion, this is the first study that shows the toxic 
effects of 3,5-DMAP on human urothelial cells. As low 
selenium status is suggested to be one of the most important 
factors in the emerging of bladder cancer, protective effects 
of both organic and inorganic selenium were also evaluated. 
Both selenocompounds were found to be protective against 
the cytotoxic, genotoxic, and ROS-producing effects of 
3,5-DMAP, which confirmed the importance of selenium 
status. Moreover, we have observed that 3,5-DMAP induced 
apoptosis can be prevented by selenium supplementation. 
Our future aim is to conduct in vivo studies that can provide 
more mechanistic information on the mode of action of 
3,5-DMAP.
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Antioksidansi i spojevi selenija inhibiraju toksično djelovanje 3,5-dimetilaminofenola na epitelne bubrežne stanice 
u ljudi
Izloženost alkilnim anilinima može uzrokovati rak mokraćnoga mjehura, koji je drugi po redu po učestalosti raka mokraćno-
spolnog sustava. 3,5-dimetilanilin često se rabi u industrijskoj proizvodnji, a istraživanja njegova primarnog metabolita, 
3,5-dimetilaminofenola (3,5-DMAP), pokazuju da on uzrokuje oksidacijski stres i promjene u aktivnosti antioksidacijskih 
enzima te u konačnici dovodi do smrti raznih stanica u sisavaca. Dosad, međutim, nije provedeno nijedno istraživanje 
njegovih izravnih učinaka na epitelne stanice mokraćnoga mjehura i bubrega u ljudi. Za spojeve selenija smatra se da 
smanjuju oksidacijski stres različitih kemikalija te da dopuna prehrane selenijem smanjuje rizik od raka mokraćnoga 
mjehura. Primarni je cilj ovoga istraživanja bio utvrditi može li organski spoj selenija selenometionin (SM, 10 µmol/L), 
odnosno anorganski spoj natrijev selenit (SS, 30 nmol/L], smanjiti oksidacijski stres, oštećenje DNA i apoptozu u UROtsa 
stanicama izloženima 3,5-dimetilaminofenolu. Jednosatna izloženost stanica 3,5-DMAP-u dovela je do povećanja razina 
reaktivnih kisikovih spojeva (ROS), lipidne peroksidacije, oksidacije bjelančevina te do promjena u aktivnosti 
antioksidacijskih enzima u staničnoj citoplazmi i jezgri, ovisno o primijenjenoj dozi. Osim toga, komet-testom su utvrđeni 
jednolančani, ali ne i dvolančani lomovi DNA. Također, 3,5-DMAP uzrokovao je apoptozu stanica. Oba su spoja selenija 
pružila djelomičnu zaštitu od njegova toksičnoga djelovanja. Nedostatak selenija pri izloženosti alkilnim anilinskim 
spojevima stoga može odigrati značajnu ulogu u nastanku raka mokraćnog mjehura. Potrebna su daljnja istraživanja 
mehanizama djelovanja selenija u njegovu sprječavanju.
KLJUČNE RIJEČI: alkilni anilini; citotoksičnost; genotoksičnost; reaktivni kisikovi spojevi; natrijev selenit; selenij; 
selenometionin
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